NCT02547623View on ClinicalTrials.gov

Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

November 6, 2015

Primary Completion Date

August 16, 2016

Study Completion Date

August 16, 2016

Conditions
Cataract
Interventions
DRUG

Dexamethasone

depot intracameral

DRUG

Prednisolone

Prednisolone eye drops 1%

Trial Locations (11)

11530

Ophthalmic Consultants of Long Island, Garden City

29464

Carolina Eye Care Physicians, Mt. Pleasant

41017

Cincinnati Eye Institute, Edgewood

45242

Cincinnati Eye Institute, Cincinnati

55082

Associated Eye Care, Stillwater

84107

the eye institute of Utah, Salt Lake City

91741

Kislinger MD inc, Glendora

92545

Inland Eye Specialists, Hemet

92653

Harvard Eye Associated, Laguna Hills

92663

Feinerman Vision Center, Newport Beach

08534

Matossian Eye Associates, Pennington

Sponsors
All Listed Sponsors
lead

ICON Bioscience Inc

INDUSTRY

NCT02547623 - Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery | Biotech Hunter | Biotech Hunter